Applied therapeutics appoints dale hooks as chief commercial officer

New york, april 15, 2024 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of dale hooks as chief commercial officer, replacing adam hansard, effective immediately. mr. hooks joins applied with over 30 years of biopharmaceutical experience in rare disease marketing and sales, holding various leadership roles. mr. hooks will be responsible for leading applied's commercial preparations for the potential launch of govorestat for the treatment of classic galactosemia and sord.
APLT Ratings Summary
APLT Quant Ranking